China Shineway Pharmaceutical Group Limited (HKG:2877)

Hong Kong · Delayed Price · Currency is HKD

7.80

-0.14 (-1.70%)

Aug 27, 2026, 10:45 AM HKT

-7.47% (1Y)

Market Cap	5.99B -5.9%
Revenue (ttm)	3.49B -17.0%
Net Income	1.06B +13.1%
EPS	1.40 +13.3%
Shares Out	755.40M
PE Ratio	5.67
Forward PE	5.38
Dividend	0.55 (6.78%)
Ex-Dividend Date	May 4, 2026

Volume	211,000
Open	7.90
Previous Close	7.94
Day's Range	7.78 - 7.92
52-Week Range	7.21 - 10.47
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 2,822

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2877

Full Company Profile

Financial Performance

In 2025, HKG:2877's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements